DE602005024964D1 - Verfahren zur beurteilung der malignität einer säuger-krebszelle - Google Patents

Verfahren zur beurteilung der malignität einer säuger-krebszelle

Info

Publication number
DE602005024964D1
DE602005024964D1 DE602005024964T DE602005024964T DE602005024964D1 DE 602005024964 D1 DE602005024964 D1 DE 602005024964D1 DE 602005024964 T DE602005024964 T DE 602005024964T DE 602005024964 T DE602005024964 T DE 602005024964T DE 602005024964 D1 DE602005024964 D1 DE 602005024964D1
Authority
DE
Germany
Prior art keywords
sensitivity
ratio
assessing
anticancer agent
irritant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005024964T
Other languages
English (en)
Inventor
Hideki Ishihara
Tomoko Matsushima
Yuko Kawasaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sysmex Corp
Original Assignee
Sysmex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sysmex Corp filed Critical Sysmex Corp
Publication of DE602005024964D1 publication Critical patent/DE602005024964D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE602005024964T 2004-05-31 2005-05-30 Verfahren zur beurteilung der malignität einer säuger-krebszelle Active DE602005024964D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004160389 2004-05-31
JP2004375639 2004-12-27
PCT/JP2005/009847 WO2005116241A1 (ja) 2004-05-31 2005-05-30 哺乳動物細胞の性質判定方法及びこれを用いた癌の診断方法

Publications (1)

Publication Number Publication Date
DE602005024964D1 true DE602005024964D1 (de) 2011-01-05

Family

ID=35450902

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005024964T Active DE602005024964D1 (de) 2004-05-31 2005-05-30 Verfahren zur beurteilung der malignität einer säuger-krebszelle

Country Status (6)

Country Link
US (1) US8921057B2 (de)
EP (1) EP1767647B1 (de)
JP (1) JP4787153B2 (de)
AT (1) ATE489622T1 (de)
DE (1) DE602005024964D1 (de)
WO (1) WO2005116241A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1840221A1 (de) * 2006-03-31 2007-10-03 Sysmex Corporation Verfahren zum Messen der Kinaseaktivität
JP4989127B2 (ja) * 2006-06-30 2012-08-01 シスメックス株式会社 チロシンキナーゼの活性測定方法及びチロシンキナーゼの基質
JP5283872B2 (ja) * 2006-09-27 2013-09-04 シスメックス株式会社 腫瘍細胞に対する阻害剤の増殖抑制効果を評価する方法、及び腫瘍細胞の増殖を阻害する化合物をスクリーニングする方法
JP5111902B2 (ja) * 2007-03-14 2013-01-09 シスメックス株式会社 癌の診断支援装置
EP2028600B1 (de) * 2007-08-24 2016-10-26 Sysmex Corporation Diagnose-Hilfssystem für Krebs, Diagnosehilfe für Informationen über das Krebsverfahren und Computerprogrammprodukt
JP5405059B2 (ja) * 2007-08-24 2014-02-05 シスメックス株式会社 がんの診断支援システム、がんの診断支援情報提供装置及びがんの診断支援情報提供方法
JP5274808B2 (ja) 2007-10-02 2013-08-28 シスメックス株式会社 がんの診断支援システム
JP2009089672A (ja) * 2007-10-10 2009-04-30 Sysmex Corp がんの再発リスクの判定方法
JP5340621B2 (ja) * 2008-03-28 2013-11-13 シスメックス株式会社 アンスラサイクリン系抗がん剤治療の有効性を判定する方法、及びアンスラサイクリン系抗がん剤治療の有効性の診断支援方法
JP5351427B2 (ja) 2008-03-28 2013-11-27 シスメックス株式会社 癌の再発リスクを判定する方法及び癌の再発リスク診断の支援方法
JP2009240238A (ja) * 2008-03-31 2009-10-22 Sysmex Corp アンスラサイクリン系抗がん剤に対するがん細胞の感受性の判定方法及び判定装置
JP2010057486A (ja) * 2008-09-02 2010-03-18 Sysmex Corp 化学療法に対するがん患者の応答の予測方法
AT508680B1 (de) * 2009-05-19 2011-03-15 Onkotec Gmbh Verfahren zur qualitativen und/oder quantitativen bestimmung von tumorzellen
JP5758690B2 (ja) * 2011-04-27 2015-08-05 シスメックス株式会社 併用化学療法の奏効性判定方法、奏効性判定プログラム及び奏効性判定装置
JP6002379B2 (ja) 2011-11-29 2016-10-05 シスメックス株式会社 癌の再発リスクの判定方法及びその利用
JP2020162420A (ja) * 2019-03-28 2020-10-08 シスメックス株式会社 サイクリン依存性キナーゼ４／６阻害剤の感受性を判定するための方法、試薬キット、装置及びコンピュータプログラム

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU705865B2 (en) * 1996-02-08 1999-06-03 Darwin Discovery Limited Resolution of 4-cyano-4-(3,4-dimethoxyphenyl) -5-methylhexanoic acid
DE19734893A1 (de) * 1997-08-12 1999-02-18 Emtec Magnetics Gmbh Lösungsmittelfrei herstellbare Polyurethane und ihre Verwendung als Bindemittel für magnetische Aufzeichnungsträger
JPH11166931A (ja) 1997-12-05 1999-06-22 Sysmex Corp 生体成分の量的あるいは質的異常を検出する方法
DE69907152D1 (de) 1998-02-18 2003-05-28 Theryte Ltd Krebsbehandlung
DE19829473C2 (de) * 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
EP1388734B1 (de) 2002-08-01 2004-03-03 MTM Laboratories AG Verfahren für Lösung-basierte Diagnose
DE60226353T2 (de) 2001-02-14 2009-06-10 Sysmex Corp., Kobe Verfahren zur Bestimmung der Aktivität des Zellzyklus-Regulationsfaktors und Verfahren zur Diagnose von Krebs unter Verwendung desselben
JP4036655B2 (ja) 2001-02-14 2008-01-23 シスメックス株式会社 細胞周期調節因子の活性の測定法と該測定法に使用される試薬
EP1600513B1 (de) * 2003-02-26 2010-02-24 Sysmex Corporation Verfahren zur untersuchung einer zelle
US7957910B2 (en) * 2005-01-31 2011-06-07 Sysmex Corporation Method for predicting effectiveness of chemotherapy

Also Published As

Publication number Publication date
EP1767647B1 (de) 2010-11-24
EP1767647A1 (de) 2007-03-28
US20070231837A1 (en) 2007-10-04
JP4787153B2 (ja) 2011-10-05
US8921057B2 (en) 2014-12-30
ATE489622T1 (de) 2010-12-15
JPWO2005116241A1 (ja) 2008-04-03
EP1767647A4 (de) 2007-08-29
WO2005116241A1 (ja) 2005-12-08

Similar Documents

Publication Publication Date Title
DE602005024964D1 (de) Verfahren zur beurteilung der malignität einer säuger-krebszelle
Saffery et al. Epigenetics as the mediator of fetal programming of adult onset disease: what is the evidence?
WO2004000094A8 (en) Predictive markers in cancer therapy
ECSP17025787A (es) Uso de paneles de genes mutantes de fgfr en la identificación de pacientes con cáncer que responderán al tratamiento con un inhibidor de fgfr
BR112014011925A2 (pt) mutações no receptor notch humano e seu uso
WO2010031056A3 (en) Methods and compositions for modulating ire1, src, and abl activity
ATE512146T1 (de) Phenylharnstoffderivate als hemmstoffe von tyrosinkinasen zur behandlung von tumorerkrankungen
BR112012014925A2 (pt) compostos promotores de replicação de células beta e métodos de uso dos mesmos
NZ588638A (en) Screening method for identifying a subject for treatment with a modified hyaluronidase polypeptides
BRPI0518086A (pt) métodos para tratamento de cáncer, métodos de avaliação de fosforilação ou ativação de her e método de identificação
NZ704295A (en) Compositions and methods for the treatment of infections and tumors
WO2006050026A3 (en) Compositions and methods for treating cancer using compositions comprising an inhibitor of endothelin receptor activity
WO2005017493A3 (en) Biomarkers in cancer
BR112012009262A2 (pt) ''método para inibir a proliferação de células de câncer positivo para ar em um indivíduo diagnosticado com,ou qual se suspeita que tenha cânce positivo para ar e método para identificar se um indivíduo é um candidato para tratamento com uma composiçâo
NZ748624A (en) Methods of selecting an individual who will benefit from treatment with a telomerase inhibitor using a formalin fixed paraffin embedded (ffpe) biological sample of solid tumor cancer cells
WO2020107002A3 (en) Methods for expansion of natural killer (nk) cell subset and related compositions and methods
ATE414277T1 (de) Verfahren zur verhinderung der zeitabhängigen rna-expression in biologischen zellen
ATE426806T1 (de) Verfahren zur prognose der wirksamkeit von chemotherapie
BRPI0608043A2 (pt) composição, método que promove a regressão do tumor, linhagem celular, método de identificação de um agente quimioterapêutico, método que promove a apoptose em células do tumor de mama, método de identificação de um agente que aumenta a apoptose em uma célula, uso de um agente e uso do ácido d-ala-l-glu-diaminopimélico
Spina et al. Liquid biopsy in tissue-born lymphomas
EP4306650A3 (de) Digitale analyse molekularer analyten mittels elektrischen verfahren
ATE459002T1 (de) Verfahren zur einschätzung des risikos maligner tumorrezidive
WO2009150491A3 (en) Interferon epsilon (ifne1) as a marker for targeted cancer therapy
BR112016004450A2 (pt) métodos para tratar uma doença, para aumentar a eficácia de um tratamento, para adiar e/ou prevenir desenvolvimento da reincidência e/ou resistência de uma doença, para aumentar a sensibilidade a um inibidor, para estender o período de sensibilidade a um inibidor e para estender a duração de resposta a um inibidor
WO2014146035A3 (en) Compositions and methods for cancer diagnosis